The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in two new lung cancer indications. The first indication is in the locally…
Everything about lung cancer is here.
The National Institute of Health and Care Excellence (NICE) has announced the recommendation of Tagrisso (osimertinib) for routine use in two new lung cancer indications. The first indication is in the locally…